Skip to content

Multi-center clinical trial on the treatment of primary dysmenorrhea by electroacupuncture in different sensitized acupoints

Multi-center clinical trial on the treatment of primary dysmenorrhea by electroacupuncture in different sensitized acupoints

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000434
Enrollment
Unknown
Registered
2025-02-27
Start date
2023-12-17
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea

Interventions

sham electroacupuncture group:Fake electroacupuncture 2 inches below Daheng point, 1 inch next to Sanyin Jiao point (both sides), 1 inch next to Diji point (both sides) shallow piercing into the skin
High-sensitivity acupoint electroacupuncture group:3 acupoints with high sensitization according to pain threshold (bilateral)
low sensitivity electroacupuncture group:The 3 points with the lowest degree of sensitization as measured by the pain threshold (bilateral)

Sponsors

The First Affiliated Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 35 Years

Inclusion criteria

Inclusion criteria: Participants must meet all of the following inclusion criteria to be admitted to this study: (1) 16 to 35 years old (including borders) female; (2) In line with Western medicine primary dysmenorrhea diagnosis; (3) In line with the standard of TCM menstrual syndrome differentiation of abdominal pain; (4) VAS score =4 points before or on the most painful 1 day of each menstrual period in the past 3 months; (5) In the past 3 months there are continuous dysmenorrhea symptoms before or on the day of menstruation; (6) Regular menstrual cycle the cycle is 21-35 days the menstrual period is 3-7 days; (7) Voluntarily participate in this clinical trial give informed consent and sign informed consent.

Exclusion criteria

Exclusion criteria: Subjects with any of the following criteria were excluded from the study: (1) Secondary dysmenorrhea caused by endometriosis, adenomyopathy, and pelvic inflammatory disease; (2) have used painkillers such as non-steroidal anti-inflammatory drugs or other methods to treat dysmenorrhea in the past 1 month; (3) Have used traditional Chinese medicine or proprietary Chinese medicine with the effect of regulating qi and removing blood stasis in the past 1 month; (4) gynecological tumors, uterine fibroids, abortion history, gynecological surgery history; (5) Use of long-acting contraceptives by injection or subcutaneous implantation within 6 months, or use of contraceptives within 8 weeks, use of medicated intrauterine devices, or preparation for pregnancy and pregnancy within 6 months; (6) Combined with serious diseases of other systems, such as liver, kidney, hematopoietic system and other serious primary diseases, tumors, mental diseases, etc.; (7) Suspected or have a history of alcohol or drug abuse; (8) acupoint local skin rupture; (9) Asthmatic patients who are allergic to emergency medication ibuprofen capsules or other non-steroidal anti-inflammatory drugs, or to aspirin; (10) Those who have participated in other clinical trials or received acupuncture, moxibustion, cupping and other physiotherapy within the field of traditional Chinese medicine within the past 1 month; (11) The investigator considers the patient unfit to participate in the study, including the investigator's judgment that the patient cannot complete the study or comply with the requirements of the study.

Design outcomes

Primary

MeasureTime frame
Duration of dysmenorrhea;NRS score of the most painful degree of dysmenorrhea;

Secondary

MeasureTime frame
The number of days with significant menstrual pain (VAS score =4 points);The use of emergency drugs;Total CMSS score for duration of dysmenorrhea symptoms;Hamilton Anxiety Scale (HAMA);Disappearance rate of dysmenorrhea pain;Dysmenorrhea NRS score time - area under the curve;Total CMSS score of dysmenorrhea symptom severity;

Countries

China

Contacts

Public ContactYue Zenghui

Hunan University of Chinese Medicine

624755064@qq.com13787293866

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026